Jacamo et al. showed that VLA-4 is upregulated in AML cells and the interaction with VCAM-1 on stromal cells activates pro-survival and proliferative pathways in both leukemia and stromal cells via the nuclear factor-κB (NF-κB) pathway and favors chemoresistance. Here, VCAM1 is linked to acute myeloid leukemia.